Inc. ASRT,This commercial pharmaceutical company owns branded prescriptions and drug-delivery technologies in the fields of neurology, inflammation, and pain management.
May I ask what will happen to this stock with the reverse stock split please?
I’ve not seen anything posted on here about this stock and wondered what everyone’s thoughts were?
Not sure why my reply didn’t carry into the merge but anyway……
With this hanging in the balance I would personally be very wary of getting involved. Purely my own opinion. DYOR and good luck.
Bausch, Assertio, Lupin must face antitrust claims over diabetes drug Glumetza | Reuters